Switch to:
More From Other Websites
Will Sanofi (SNY) Prove to be a Suitable Value Stock? Mar 22 2017
Sanofi Genzyme Extends its Multiple Myeloma Journey Partners Program to Cities Nationwide to Help... Mar 22 2017
Sanofi and Regeneron Sue Amgen over Eczema Drug Mar 21 2017
Sanofi-Genzyme files preemptive legal strike to protect eczema drug Mar 21 2017
Sanofi, Regeneron sue Amgen to protect eczema drug from patent claims Mar 21 2017
Sanofi Announces Results of First-of-Its-Kind Social Experiment Revealing Real-Life Impact of... Mar 21 2017
Our Ultimate Stock-Pickers' Top 10 Dividend-Yielding Stocks Mar 21 2017
[$$] Sanofi's Prescription for Growth: Drug Sales in the Middle Kingdom Mar 21 2017
Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop Mar 20 2017
Esperion's Dive On Amgen Heart Study 'Counterintuitive' On Pricing Mar 17 2017
Amgen's Repatha Reduced Heart Attack, Stroke Risk Mar 17 2017
The Zacks Analyst Blog Highlights: U.S. Bancorp, Verizon, EOG Resources, Sanofi and Nokia Mar 17 2017
What are Sanofi's (SNY) Strengths and Challenges in 2017? Mar 17 2017
New Stock Research Reports for Verizon, EOG, and U.S. Bancorp Mar 16 2017
Sanofi, Regeneron’s Dupilumab Gets UK Early Access Mar 15 2017
Bernie Sanders Slams Sanofi Zika Vaccine Deal Mar 15 2017
Sanofi and Voluntis Ink Global Pact for Diabetes Mar 15 2017
Amgen's Repatha Meets Primary Endpoint in Phase III Study Mar 14 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK